Chad Patel

OMNI® surgical system versus iStent inject® with concomitant cataract surgery for the treatment of mild-to-moderate primary open-angle glaucoma in the United States: a cost utility analysis

D. Franić, L. Cantor, C. Masseria, 2023, Expert Review of Ophthalmology.

The budget impact of introducing the OMNI® surgical system to a United States health plan for managing mild-to-moderate primary open-angle glaucoma

L. Cantor, C. Masseria, J. Dickerson, 2023, Expert review of pharmacoeconomics & outcomes research.